<DOC>
	<DOCNO>NCT01725789</DOCNO>
	<brief_summary>This study design evaluate efficacy Ferinject® improve acute isovolemic anemia gastrectomy gastric cancer term Quality life ( QOL ) objective measure ( Hb iron parameter ) . Furthermore , tolerability safety Ferinject® treatment evaluate .</brief_summary>
	<brief_title>Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia ( FAIRY )</brief_title>
	<detailed_description>Randomized patient-blind placebo control study . Hb level 10 g/dl use cut-off value study base guideline publish American Society Clinical Oncology American Society Hematology treatment cancer-related anemia , recommend Hb &lt; 10 g/dl treatment threshold . Ferinject® administer base Hb body weight per approve summary product characteristic ( SmPC ) . 5 - 7 day gastrectomy gastric cancer , consent patient 7g/dl≤Hb &lt; 10g/dl administer Ferinject® placebo ( normal saline ) base result randomization . • Study Group Ferinject®to administer IV drip infusion undiluted bolus injection minimum administration time 15minutes ( 1000mg single administration ) body weight ≥50 Kg 6 minute ( 500mg single administration ) body weight &lt; 50Kg . Note , Ferinject® administer maximum 20mg iron/kg . Therefore patient body weight &lt; 50kg , administration Ferinject® limit 500mg baseline . All patient serum ferritin value &lt; 15ng/mL week 4 visit second dose ( 500mg iron equivalent placebo ) give . ( Study group : Ferinject®500mg , Control Group : Placebo ) • Control Group Placebo form normal saline administer time period equivalent Ferinject® administration . IV drip infusion undiluted bolus injection minimum administration time 15 minute ( 200mL infusion 20mL bolus injection ) body weight ≥50 Kg 6 minute ( 100mL normal infusion 10mL bolus injection ) body weight &lt; 50 Kg .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>≥ 20 year old 7g/dl ≤ Hb &lt; 10g/dl 5 7 day gastrectomy gastric cancer sign write informed consent concurrent medical condition ( ) would prevent compliance participation jeopardize health patient hypersensitivity component formulation active severe infection/inflammation History transfusion , erythropoietin , &gt; 500 mg intravenous iron administration within 4 week prior screen . History acquire iron overload . Pregnancy lactation . Decreased renal function ( defined creatinine clearance &lt; 50 mL/min calculate CockcroftGault ) Chronic liver disease increase liver enzyme ( ALT , AST ) &gt; 3 time upper limit normal range . Participation interventional study within 1 month prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Acute isovolemic anemia gastrectomy gastric cancer</keyword>
</DOC>